“The Universidad del Rosario, working jointly with the Foundation Institute of Colombian Immunology, is engaged on a project to develop
a synthetic vaccine against tuberculosis, one that will improve quality of life for millions,” says Marisol Ocampo, professor of the School of Medicine and Health Sciences and coordinator of the FIDIC Tuberculosis Group.